BIONET Therapeutics Corp. (TPEX:7808)
Taiwan · Delayed Price · Currency is TWD 34.95
-0.05 (-0.14%)
At close: Sep 17, 2026
BIONET Therapeutics Market Cap
BIONET Therapeutics has a market cap or net worth of 2.45 billion as of September 17, 2026. Its market cap has decreased by -37.81% in one year.
Market Cap
2.45B
Enterprise Value
1.44B
Revenue
196.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.95
ChartMarket Cap Chart
Since December 12, 2024, BIONET Therapeutics's market cap has decreased from 3.82B to 2.45B, a decrease of -35.87%. That is a compound annual growth rate of -22.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 2.45B | -37.81% |
| Dec 31, 2025 | 3.93B | 20.99% |
| Dec 31, 2024 | 3.25B | -14.77% |
| Dec 12, 2024 | 3.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 19.53B |
| Elixiron Immunotherapeutics (Cayman) Limited | 18.80B |
| Intelligene | 7.05B |
| Tripartite Therapeutics | 6.09B |
| Uwell Biopharma | 6.05B |
| Obigen Pharma | 5.38B |
| Pet Pharm Biotech | 3.13B |
| FullHope Biomedical | 1.33B |